SPMS health costs are high, and higher still for younger patients and those with severe disability, a real-world study in ...

Functional neurological disorder can be hard to distinguish from other conditions. Some patients feel misunderstood and their ...

New research highlights how multimorbidity significantly worsens survival and physical function in patients with systemic sclerosis, underscoring the need for holistic care strategies.

Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in ...

Foralumab is the first fully human anti-CD3 monoclonal antibody administered via the intranasal route. This novel, non-systemic approach is designed to engage regulatory T cells, promoting immune ...

Scientists in Sweden have taken an important step forward in understanding how a very common virus, called Epstein-Barr virus ...

TGTX surges 200% in 2023 on Briumvi's MS success. With Q1'25 earnings ahead, see here for TGTX stock's sales trends, new ...

Southeast Missouri’s chapter of the National Multiple Sclerosis Society offers support to people diagnosed with or caring for ...

One year of Tysabri infusion improved working ability for relapsing-remitting multiple sclerosis (RRMS) patients in France, ...

A novel AI tool called MindGlide extracts key biomarkers from MRI scans to help interpret and assess treatment efficacy in ...

Multiple sclerosis (MS) is a chronic autoimmune disorder affecting the central nervous system, often emerging in early adulthood and representing a leading cause of neurological disability in young ...

HIGHER lesion burden in the uncinate fasciculus (UF), a key brain pathway linking emotional regulation regions, is associated with increased anxiety severity in multiple sclerosis (MS) patients, ...